Stanford Pragmatic Effectiveness Comparison
NCT04441034 · Status: RECRUITING · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 450
Last updated 2026-05-22
Summary
Chronic pain is a major healthcare problem with an annual cost of above $600 billion. The quality of data available for treatments of chronic pain is not optimal. Generalizability of explanatory randomized controlled trial data is problematic as these trials exclude up to 90% of patients: leaving out real-world patients with serious medical and psychological comorbidities. Pragmatic trials embedded in patient care compare effectiveness of currently used treatments in real-world application leading to findings that generalize to broader range of patients.
The changes in clinical practice and workflow necessary to integrate this type of research within patient care present pragmatic challenges. In this research, the overall objective is to overcome these challenges using an open-source learning health care system - CHOIR. CHOIR is currently used to track patients' clinical trajectory and treatment response across multiple academic sites resulting in over 25 publications characterizing chronic pain. Through the pilot studies, the investigators have already developed a point-of-care randomization for CHOIR that facilitates integration of research and patient care by allowing the physicians to randomize patients during clinic visits. The investigators have already demonstrated feasibility of the randomization and data collection platform in two ongoing pilot pragmatic clinical trials.
The investigators are proposing to better integrate pragmatic research within clinical practice through conducting a randomized comparative effectiveness trial in 450 patients with chronic pain comparing effectiveness of anti-convulsants and anti-depressants (two most commonly used classes of medications for treatment of chronic pain). The investigators will also perform a qualitative interview with all physicians in our clinic to study the impact of integrating pragmatic research into clinical care. The investigators will use the data available in CHOIR as well as the real-world data generated from this clinical trial to build, validate and test a model to predict what clinical characteristics can predict response to either of these classes of medications.
The proposed study is the first step to use flexible point-of-care randomization to compare effectiveness of different treatments in different subgroups of patients whenever equipoise exists. The prediction model will guide decision making process of clinicians choosing between these medications based on clinical characteristics of individual patients.
Conditions
Interventions
- DRUG
-
Anti-convulsant medications
Anti-convulsants are very commonly used to treat patients with chronic pain.
- DRUG
-
Anti-depressant medications
Anti-depressants are very commonly used to treat patients with chronic pain.
Sponsors & Collaborators
- lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-04-12
- Primary Completion
- 2027-04-30
- Completion
- 2027-04-30
- FDA Drug
- Yes
Countries
- United States
Study Locations
More Related Trials
-
Study of Pregabalin Versus Placebo in the Treatment of Nerve Pain Associated With HIV Neuropathy
NCT00232141 ·Status: COMPLETED ·Phase: PHASE3
-
Pharmacodynamic Study of 300mg Pregabalin vs Placebo in Healthy Male Adults
NCT06600607 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Evaluate Long-Term Safety and Efficacy of Pregabalin in Patients With Chronic Neuropathic Pain.
NCT00141362 ·Status: COMPLETED ·Phase: PHASE3
-
Neuropathic Pain Syndrome Patient Study (MK-0000-072)
NCT00570310 ·Status: COMPLETED ·Phase: PHASE1
-
Chronic Low Back Pain Research Project
NCT00108550 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Pregabalin in Patients With Radiotherapy-related Neuropathic Pain
NCT01869569 ·Status: COMPLETED ·Phase: PHASE2
-
Pregabalin Versus Placebo In The Treatment Of Neuropathic Pain Associated With HIV Neuropathy
NCT01049217 ·Status: TERMINATED ·Phase: PHASE3
-
Increased Sensitivity to Pain Caused by Opioids in People Who Have Abused Prescription Opioids
NCT01821430 ·Status: TERMINATED ·Phase: PHASE2
-
Placebo-controlled Safety and Efficacy Study of Pregabalin in Subjects With Post-traumatic Peripheral Neuropathic Pain
NCT01701362 ·Status: COMPLETED ·Phase: PHASE3
-
Pregabalin Treatment and Prevention Post-herpetic Neuralgia
NCT03186443 ·Status: UNKNOWN ·Phase: PHASE3
-
A Study to Evaluate Pregabalin in Painful Diabetic Peripheral Neuropathy
NCT06383702 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
A Study to Assess the Safety and Efficacy of 7 Days Treatment With a Novel Analgesic in Subjects With Peripheral Neuropathic Pain
NCT01485094 ·Status: TERMINATED ·Phase: PHASE2
-
The Efficacy and Safety of Pregabalin Release Tablets for the Treatment of Fibromyalgia
NCT02868814 ·Status: UNKNOWN ·Phase: PHASE3
-
Donepezil Compared to Placebo in Patients With Chronic Neuropathic Pain
NCT01743976 ·Status: TERMINATED ·Phase: PHASE4
-
Mechanism-based Choice of Therapy for Neuropathic Pain
NCT01359514 ·Status: COMPLETED ·Phase: NA
-
Symptom Based Treatment of Neuropathic Pain
NCT02180880 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of Preventional Drug Therapy on Pain Regulation Mechanisms Among SCI
NCT03748290 ·Status: UNKNOWN ·Phase: PHASE4
-
Gabapentin in Treating Peripheral Neuropathy in Cancer Patients Undergoing Chemotherapy
NCT00027963 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Assess the Efficacy, Safety and Tolerability of Pregabalin in Patients With Symptoms of Neuropathic Pain
NCT00301223 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of the Safety and Tolerability of GA in the Treatment of Patients With Refractory Neuropathic Pain
NCT06596681 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
'Fix the Dysfunction' Concept for Mechanism-based Pharmacological Treatment of Neuropathic Pain by Drug
NCT03276689 ·Status: COMPLETED ·Phase: NA
-
Gabapentin on Postoperative Pain Associated With Ureteroscopy and Stents Insertion
NCT03151746 ·Status: TERMINATED ·Phase: PHASE4
-
Gabapentin and Tizanidine for Insomnia in Chronic Pain
NCT04429347 ·Status: COMPLETED ·Phase: PHASE2
-
Comparative Study Of Pregabalin And Gabapentin As Adjunctive Therapy In Subjects With Partial Seizures
NCT00537940 ·Status: COMPLETED ·Phase: PHASE4
-
Placebo In Chronic Back Pain (Phase 2)
NCT02986334 ·Status: COMPLETED ·Phase: PHASE4